CSBR:NASDAQ
Champions Oncology Inc
US$4,78
arrow_upward
+0,63%(+0,030) 1D
11 ພ.ຈ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
US$4,79
High
US$4,81
Low
US$4,64
Mkt. cap
66,53 ລ້ານ
Avg. vol.
8,97 ພັນ
Volume
0,00
52-wk high
US$8,31
52-wk low
US$4,63
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
Open
US$4,79
High
US$4,81
Low
US$4,64
Mkt. cap
66,53 ລ້ານ
Avg. vol.
8,97 ພັນ
Volume
0,00
52-wk high
US$8,31
52-wk low
US$4,63
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
News stories
From web sources and news partners
TradingView
·
1 ຊົ່ວໂມງກ່ອນ
Stock Market: Will S&P 500 Open Up or Down Today?
FOREX.com
·
13 ຊົ່ວໂມງກ່ອນ
S&P 500 Forecast: SPX rebounds amid revived AI enthusiasm
Eurasia Business News
·
11 ຊົ່ວໂມງກ່ອນ
Stock Market Today: Dow Jones, Nasdaq, S&P 500 Rally on November 11, 2026; Oil Rises, Gold Slips
Traders Union
·
9 ຊົ່ວໂມງກ່ອນ
Peter Tuchman: S&P 500 gains over $900 billion in market cap, closing up 1.3 percent
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ນິວເຈີຊີ, ສະຫະລັດ
SectorHealth Care
Industry-
Websitechampionsoncology.com